<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>识林 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-23T07:25:08+08:00</updated>
  <subtitle>服务于制药行业企业、机构及人员的知识与管理平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>欧洲药典发布亚硝胺通则，更新 CEP 认证的当前状况</title>
    <updated>2020-12-23T06:35:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/f4hN7rN-pPbiZunLMKjgQw</id>
    <link href="https://mp.weixin.qq.com/s/f4hN7rN-pPbiZunLMKjgQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 发布疫情期间审评时限指南，试图降低申请人期望减少抱怨</title>
    <updated>2020-12-23T06:35:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/EpEMhS91al0OIh1FG8v1CA</id>
    <link href="https://mp.weixin.qq.com/s/EpEMhS91al0OIh1FG8v1CA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧盟附条件批准辉瑞-BioNTech 新冠疫苗</title>
    <updated>2020-12-22T06:36:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/2d4DHxnaELbhy_CLtr0Xhw</id>
    <link href="https://mp.weixin.qq.com/s/2d4DHxnaELbhy_CLtr0Xhw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>印度新冠疫苗试验不良反应引发质疑，辉瑞疫苗需要在印度本地试验</title>
    <updated>2020-12-22T06:36:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/oB5EUKb2brwIgHZVH7BokQ</id>
    <link href="https://mp.weixin.qq.com/s/oB5EUKb2brwIgHZVH7BokQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一周回顾：经口吸入仿制药生物等效性指导，AAV基因治疗产品CMC开发案例解析，FDA授权第二个新冠疫苗，欧盟转基因细胞产品指南</title>
    <updated>2020-12-21T06:40:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/-cJr0RJhYNT6oz201fjtnQ</id>
    <link href="https://mp.weixin.qq.com/s/-cJr0RJhYNT6oz201fjtnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧盟基因和细胞治疗药物开发指南，含CAR-T细胞特殊临床考虑</title>
    <updated>2020-12-21T06:40:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/G_a1AmpUnnVNVJHBFJgblw</id>
    <link href="https://mp.weixin.qq.com/s/G_a1AmpUnnVNVJHBFJgblw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【周末杂谈】法律、律师与 FDA</title>
    <updated>2020-12-20T06:33:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/36VD_eeS-y1ru1IjeDdBTw</id>
    <link href="https://mp.weixin.qq.com/s/36VD_eeS-y1ru1IjeDdBTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗领跑者已撞线，后来者面临更多试验执行困难</title>
    <updated>2020-12-19T06:43:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/JBx3N56fKbehdz2b5ZNzIQ</id>
    <link href="https://mp.weixin.qq.com/s/JBx3N56fKbehdz2b5ZNzIQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【快讯】Moderna 新冠疫苗专家会意见，20-0 支持紧急使用授权</title>
    <updated>2020-12-18T06:30:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/86b_ADmMv76DVCyuig80Rw</id>
    <link href="https://mp.weixin.qq.com/s/86b_ADmMv76DVCyuig80Rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA专家会幻灯片：Moderna新冠疫苗作用机理、有效性、安全性和临床观点</title>
    <updated>2020-12-18T06:30:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/zGARsqWYhX7w9FaDwTkZvw</id>
    <link href="https://mp.weixin.qq.com/s/zGARsqWYhX7w9FaDwTkZvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧盟新冠疫苗专家投票日期提前，使用附条件批准路径</title>
    <updated>2020-12-17T06:45:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/fk1KJScLGr-k3qDYN66ZEw</id>
    <link href="https://mp.weixin.qq.com/s/fk1KJScLGr-k3qDYN66ZEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 发布仿制药研发受控函定稿指南</title>
    <updated>2020-12-17T06:45:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/cgqpiFpEVxiS7fObhAIBlg</id>
    <link href="https://mp.weixin.qq.com/s/cgqpiFpEVxiS7fObhAIBlg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>免费线上讲座：FDA 生物制品研发、合规监管体系与检查优先级</title>
    <updated>2020-12-16T07:27:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/eCdJ8K43MvFvAJXZlJ7-oA</id>
    <link href="https://mp.weixin.qq.com/s/eCdJ8K43MvFvAJXZlJ7-oA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Moderna 新冠疫苗专家会会前资料，非常有效但不良反应更多</title>
    <updated>2020-12-16T07:27:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/YIni4-EGhX_CUZ-cLORiQw</id>
    <link href="https://mp.weixin.qq.com/s/YIni4-EGhX_CUZ-cLORiQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧洲药品监管 2025 战略关注药品可及性和供应链挑战</title>
    <updated>2020-12-15T06:47:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/lcyZaJd7leTUBxIu-aE4_g</id>
    <link href="https://mp.weixin.qq.com/s/lcyZaJd7leTUBxIu-aE4_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新全球联盟推动分散式临床试验的实施</title>
    <updated>2020-12-15T06:47:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/-pdWn2gyhA_XpbXl5c9auQ</id>
    <link href="https://mp.weixin.qq.com/s/-pdWn2gyhA_XpbXl5c9auQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一周回顾：药品年度报告管理规定和模板，药物研发审评沟通交流办法，FDA 授权首个新冠疫苗，欧盟药品监管网络2025战略</title>
    <updated>2020-12-14T06:34:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/A120Yybi2k_TLDrkfF_mIw</id>
    <link href="https://mp.weixin.qq.com/s/A120Yybi2k_TLDrkfF_mIw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 现场检查替代计划进展缓慢导致关键新药审批停滞</title>
    <updated>2020-12-14T06:34:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/Wq3vi7ujo3B_4-UtI0YhKg</id>
    <link href="https://mp.weixin.qq.com/s/Wq3vi7ujo3B_4-UtI0YhKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>